Twitter Beğeni Hilesi

Very nice discussion and conclusion by Camilla Zimmermann MD PhD! Trials in #suppcare are complex and challenging but we need them to improve QoL and management of our patients! ESMO - Eur. Oncology OncoAlert #ESMO23

Amazing conclusion of the first Presidential by Benjamin Besse discussing PAPILLON and LIBRETTO-431. Positive trials but huge amount of resources needed. Risk of preventing pts access to active drugs. Let’s find solutions to stop the *unnecessary*. ESMO - Eur. Oncology OncoAlert #ESMO23

Inspiring as always, Prof. Matteo Lambertini, MD PhD todays talk about short- and long-term side effects in AYA patients, main topic in our daily clinical practice 🚨🔥

Super #ESMOYOC brunch: communicate research. 🔸Know your message, tailor to the audience, make the listener “think, feel and do” ❗️Attention span ~8 sec: be compelling 🧠People remember stories more than numbers Thanks Pawel Sobczuk and Rille for the amazing session!

Proud of you ElenaCroce! Very relevant topic: early discontinuation of Cemiplimab after response for CSCC appears safe. Need to test discontinuation of IO in trials to reduce financial and toxicity burden!

The Università di Genova Ospedale San Martino Genova crew at #ESMO23 🇮🇹❤️🤩💪🔝 Lucia Del Mastro ESMO - Eur. Oncology OncoAlert Marco Tagliamento Francesco Spagnolo Carlo Genova Diletta Favero Eva Blondeaux Roberto Borea Davide Soldato Benedetta Conte

🙌Hey UTSW Simmons Cancer Center UTSWCancerBio UTSW Science UTSW Hematology & Oncology UTSW Immunology UTSW Department of Pathology, check out Fabiana Napolitano's seminar next Thurday! Carlos L. Arteaga, M.D. #BreastCancer #EndocrineResistance #TME #proudmentor

Check out the latest from the amazing Benedetta Conte! Very important results to undergoing biological mechanisms and adequately select patients for extended HT! Stay tuned! #bcsm OncoAlert

Don't forget to register for our upcoming webinar on Precision Oncology on Nov 13 Speakers: Maryam Lustberg MD, MPH, FASCO Kevin Kalinsky, MD, MS Ines Vaz Luis Dawn Hershman Stacey Tinianov (she/her) MPH, BCPA Learn more or register here: us02web.zoom.us/webinar/regist… #SuppOnc

Findings of this review of #PalliativeCare RCTs in non-cancer illness suggest that most #PROs of #QoL were neither derived nor validated among populations with advanced life-limiting illness: liebertpub.com/doi/10.1089/jp…

Super, incredible Matteo Lambertini, MD PhD at #SABCS23, reporting results from the largest international cohort study on pregnancy after BC in young gBRCAmut carriers. This data has huge impact on our daily practice and on patients' lives. Thank you and congratulations!

Huge congratulations Matteo Lambertini, MD PhD for leading this massive 🌎 effort reassuring about the safety of pregnancy after BC in young pts w/ BRCA PVs New milestone for #BC oncofertility counseling!🤱 Concomitant pub. JAMA: ja.ma/481Zd88 SABCS OncoAlert

Presented at #SABCS23 results from #INAVO120 trial showing PFS benefit with the addition of #inavolisib to #fulvestrant and #palbociclib as first-line therapy in patients with endocrine-resistant #PIK3CA mutated advanced #BreastCancer SABCS OncoAlert #bcsm

Sexual concerns are prevalent at BC dx and increase or persist after treatment with <50% of pts receiving support. How to change this? MDT & coordinated referrals ➡️ proactive care pathways Empower pts & providers (communication + knowledge on validated support) ➡️ e-health

🧵 Review Article: Key Issues as Wearable Digital Health Technologies Enter Clinical Care Wearable digital health technologies (DHTs) are devices that record behavioral or physiological data for use in medical decision making about the wearer. 1/9 #DigitalHealth

Presented at #ASCO24 by Luca Arecco, MD and now out in Annals of Oncology…really grateful to all that have made the #BRCA BCY collaboration possible…another important news for the counseling of young women with #BreastCancer OncoAlert Università di Genova Ospedale San Martino Genova #bcsm Eva Blondeaux

Go check out the amazing work led by Francesca Poggio on efficacy of adjuvant chemotherapy schedules according to BMI!